These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20959591)

  • 1. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease.
    Gupta SK; Bang C; Thum T
    Circ Cardiovasc Genet; 2010 Oct; 3(5):484-8. PubMed ID: 20959591
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating miRNAs: messengers on the move in cardiovascular disease.
    Egea V; Schober A; Weber C
    Thromb Haemost; 2012 Oct; 108(4):590-1. PubMed ID: 22955179
    [No Abstract]   [Full Text] [Related]  

  • 3. microRNAs as peripheral blood biomarkers of cardiovascular disease.
    Di Stefano V; Zaccagnini G; Capogrossi MC; Martelli F
    Vascul Pharmacol; 2011 Oct; 55(4):111-8. PubMed ID: 21846509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
    Fichtlscherer S; Zeiher AM; Dimmeler S
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2383-90. PubMed ID: 22011751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.
    Kumarswamy R; Anker SD; Thum T
    Circ Res; 2010 May; 106(9):e8; author reply e9. PubMed ID: 20466983
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular markers for cardiovascular disease: cardiovascular biomarkers to proteomic discovery.
    Suzuki T; Nagai R
    Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):295. PubMed ID: 18506210
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature.
    Schöler N; Langer C; Döhner H; Buske C; Kuchenbauer F
    Exp Hematol; 2010 Dec; 38(12):1126-30. PubMed ID: 20977925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as biomarkers for hepatocellular carcinoma.
    Qu KZ; Zhang K; Li H; Afdhal NH; Albitar M
    J Clin Gastroenterol; 2011 Apr; 45(4):355-60. PubMed ID: 21278583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of circulating microRNA on clinical diagnosis of cardiovascular diseases].
    Nie Y; Liu Z; Chen X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):377-82. PubMed ID: 21624320
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating miRNAs as a new class of biomedical markers].
    Baulande S; Criqui A; Duthieuw M
    Med Sci (Paris); 2014 Mar; 30(3):289-96. PubMed ID: 24685220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans.
    Li T; Cao H; Zhuang J; Wan J; Guan M; Yu B; Li X; Zhang W
    Clin Chim Acta; 2011 Jan; 412(1-2):66-70. PubMed ID: 20888330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.
    Corsten MF; Dennert R; Jochems S; Kuznetsova T; Devaux Y; Hofstra L; Wagner DR; Staessen JA; Heymans S; Schroen B
    Circ Cardiovasc Genet; 2010 Dec; 3(6):499-506. PubMed ID: 20921333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs: Association with disease and potential use as biomarkers.
    Reid G; Kirschner MB; van Zandwijk N
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):193-208. PubMed ID: 21145252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter by D'Alessandra et al regarding article, "Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease".
    D'Alessandra Y; Pompilio G; Capogrossi MC
    Circ Cardiovasc Genet; 2011 Feb; 4(1):e7; author reply e8. PubMed ID: 21325158
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
    Welsh P; Packard CJ; Sattar N
    Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of microRNAs in cardiovascular disease.
    Maegdefessel L
    J Intern Med; 2014 Dec; 276(6):633-44. PubMed ID: 25160930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemostasis, inflammation and cardiovascular disease.
    Páramo JA; Orbe J
    Clin Lab; 2002; 48(9-10):463-70. PubMed ID: 12389705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.